< Back to previous page


Development, evaluation and optimization of ocular drug delivery concepts for the use in dry eye syndrome and retinal disorders.

Several ocular drug delivery concepts will be developed, characterized in vitro and ex vivo and evaluated in vivo. First the peptide cyclosporine is selected for the development of the concepts. Afterwards, the most promising formulation will be further developed for retinal disorders with a specific peptide.
Date:1 Sep 2009 →  31 Aug 2011
Disciplines:Ophthalmology and optometry, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences